Effects of Clean Intermittent Catheterization on Adherence in Pediatric Renal Transplant Patients

Sarah Ashley1, Arun Chandnani2, Carter Sevick3

  • 1University of Colorado School of Medicine, Aurora, Colorado, USA.

Pediatric Transplantation
|January 28, 2026
PubMed

Insights

Pediatric kidney transplant candidates requiring clean intermittent catheterization (CIC) showed lower treatment adherence. Older age also increased non-adherence risk, highlighting the need for early interventions in these vulnerable patients.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Pediatric Medicine

Background:

  • Treatment adherence is critical for successful kidney transplant outcomes.
  • The impact of clean intermittent catheterization (CIC) on adherence in pediatric transplant candidates is not well understood.

Purpose of the Study:

  • To investigate the association between medical diagnostic factors and treatment adherence in pediatric kidney transplant candidates.
  • To evaluate the role of CIC and patient age in predicting adherence using the Pediatric Transplant Rating Instrument (P-TRI).

Main Methods:

  • A retrospective chart review of 180 pediatric kidney transplant candidates was conducted.
  • Data included demographics, diagnosis, catheterization status, and age.
  • Adherence was assessed using a P-TRI subscale, with cumulative logistic regression analyzing differences.

Main Results:

  • Patients using CIC pre-transplant had significantly lower adherence scores (OR 0.46, p=0.021).
  • Older age correlated with decreased adherence (Spearman correlation -0.25, p<0.001).

Conclusions:

  • Pre-kidney transplant CIC use is a risk factor for lower patient adherence.
  • Older pediatric patients are also at higher risk for non-adherence.
  • Identifying these risk factors allows for targeted interventions to optimize adherence in transplant candidates.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
942
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202